Stock Information
Agios Pharmaceuticals Inc (AGIO)
Ticker Symbol: AGIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,639.99 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -7.2504
Revenue (TTM): $1.12 M
Dividend Yield: N/A%
ROE: -34.11%
Latest News
-
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
Tue, May 12, 2026 1:31 PM
-
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
Tue, May 12, 2026 1:30 PM
-
Agios Pharmaceuticals Submits Supplemental New Drug Application To FDA Seeking Accelerated Approval Of Oral Pyruvate Kinase Activator Mitapivat; To Also Present New Data On Mitapivat At 31st European Hematology Association Congress
Tue, May 12, 2026 9:35 AM
Key Financials
Financial data not available
